跳至主要内容
临床试验/NCT06631781
NCT06631781招募中不适用

Cognitive Control Amongst Older Adults with Depressive Symptom: Mechanisms and Intervention

Hebrew University of Jerusalem1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2024年2月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
42
试验地点
1
主要终点
Adaptive Cognitive Evaluation (ACE) Battery

研究概览

简要总结

The prevalence of depressive symptoms in older adults is on the rise, affecting 13 to 37% of older adults globally. These symptoms significantly impact health, increasing the risk of dementia and cognitive decline, and impairing daily functioning and quality of life. Reduced cognitive control (CC) is a key factor contributing to depressive symptoms, affecting 40% of adults with such symptoms. Despite this, over half of affected adults do not respond well to available treatments. Computerized cognitive training (CCT) has shown efficacy in improving CC but its impact on daily functioning is limited. The Cognitive Orientation to Occupational Performance (CO-OP) approach has demonstrated promise in improving daily functioning, as measured by occupational performance (OP). We propose a novel intervention, GOLD-Cog+, combining CCT and CO-OP, to address CC and functional deficits in older adults with depressive symptoms.

详细描述

The goal of this clinical trial is to investigate the relationship between mood and cognitive control in community-dwelling older adults (65+) with sub-clinical depression and to assess feasibility, efficacy, and sustainability of a proposed combined cognitive intervention, GOLD-Cog+, for this population group. Cognitive control is the mental abilities that underlie our goal-directed behavior. These mental abilities include: the ability to shift our attention, constantly monitoring and updating information provided by our environment and having the ability to inhibit unwanted reactions.

The main questions of this study are:

Question 1: What is the relationship between mood and cognitive control in daily life of older adults with depressive symptoms? Question 2: Can this proposed combined cognitive intervention, GOLD-Cog+ help improve daily functioning, cognitive control, mood, quality of life and subjective cognition in older adults with depressive symptoms? Question 3: Are the participants satisfied with this new proposed intervention?

Participants will participate in a crossover randomized control trial in which they will participate in a 6-week experimental period and a 6-week waiting period. During the experimental period, they will take part in individual computerized cognitive training and functional-based, goal-oriented group sessions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Depressive Symptoms based on Patient Health Questionnaire (PHQ-8) ≥ 5
  • Healthy Cognition based on Montreal Cognitive Assessment (MoCa) ≥ 20
  • Capable of signing and agreeing to participate in the study
  • Have the basic technological skills to use a tablet based on self-report
  • Adequate sight and hearing abilities (with assistive technology) to be able to use a tablet and fully participate in a small group setting (6 people)
  • Ability to fluently read, speak and understand Hebrew or English

排除标准

  • Any neurodegenerative disorder (e.g., Mild Cognitive Impairment (MCI), Dementia, Parkinson's disease) via self-report
  • Psychiatric disorders, not including depression or anxiety disorders (specifically: Schizophrenia, Bipolar or Psychotic disorders) via self-report

结局指标

主要结局

Adaptive Cognitive Evaluation (ACE) Battery

时间窗: Pre-test, post-test (7-weeks after pre-test)

An online assessment tool, comprised of 6 sub-tasks based on standardized tests to assess cognitive control (inhibition, shifting, monitoring) in an immersive and user-friendly interface

Canadian Occupational Performance Measure (COPM)

时间窗: Pre-test, post-test (7-weeks after pre-test)

Used to measure functioning by measuring occupational performance. The COPM is a semi-structured interview rating clients' self-perception of performance and satisfaction in their five most important functional problems. Importance, performance, and satisfaction for each goal are rated on a 10-point Likert scale, with 1 denoting not important at all, not satisfied at all and not able to do it at all, and 10 denoting extremely important, able to do it extremely well and extremely satisfied, respective of the scale used

次要结局

  • Beck Depression Scale (BDI-II)(Pre-test, post-test (7-weeks after pre-test))
  • State Trait Anxiety Inventory (STAI) tool(Pre-test, post-test (7-weeks after pre-test))
  • The Older People's Quality of Life (OPQoL-35)(Pre-test, post-test (7-weeks after pre-test))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mor Nahum

Professor

Hebrew University of Jerusalem

研究点 (1)

Loading locations...

相似试验